Rockwell Medical names Charlie Shiner new vice president, Marketing
4 December 2018 -

Rockwell Medical Inc (NASDAQ: RMTI), a biopharmaceutical company, announced yesterday that it has named Charlie Shiner as its new vice president, Marketing, effective immediately.

Shiner will report to Stuart Paul, president & chief executive officer of the company.

Shiner joins Rockwell Medical from Otsuka Pharmaceuticals Ltd. He most recently served as the marketing franchise leader for Otsuka's renal portfolio, where he successfully launched Otsuka's new therapeutic Jynarque and managed other key renal therapeutics. Previously, he held the roles of director and senior product manager, Digital Marketing at Otsuka America Pharmaceuticals. Earlier in his career, Shiner spent 11 years at Pfizer Inc where among other roles, he worked to identify and execute upon strategic opportunities for Pfizer's clinical treatments within hospital accounts across the United States.